Health Condition 1: null- Patient with open wound
Conditions
Interventions
Intervention1: Chitosan Treated Cotton Gauze (CTC): Chitosan Treated Cotton Gauze (CTC)
- The drug would be applied for three days and OD dosage.
Intervention2: Tetracycline drug applied on Chitosan T
Sponsors
Mr Sakthivel Perumalsamy
Eligibility
Inclusion criteria
Inclusion criteria: •Age >18 years of both sex •Subjects with any general wound which is open •Wound should be partial thickness in classification and should be less than or equal to 2 inches (5 cm) in diameter •Subjects currently does not need the administration of any other antibiotic course or any other intensive treatment methods, as per the investigatorâ??s discretion •Subjects without any major health problem which may have an effect on the study results as per the investigatorâ??s discretion •Subjects should be able to comply with the study procedures and schedules •Subjects should be able to understand study information provided and give written informed consent after being explained to by the physician. She/he must be aware of the experimental nature of the therapy, its potential benefits, side effects, risks and discomforts
Exclusion criteria
Exclusion criteria: •Immunocompromised subjects •Subjects with the addiction to cigarettes, alcohol and narcotics, including opium •Subjects with the known history of major illness /disorders as per the Investigatorâ??s discretion •Subjects with documented hypersensitivity reaction to Chloramphenicol •Subjects with documented hypersensitivity reaction to Chitosan •Subjects with documented hypersensitivity reaction to Tetracycline •Subjects with documented hypersensitivity reaction to Oxytetracycline •Pregnant Women •Breast feeding Women •Patient/Legally acceptable representative; who is unable to give consent •Patient who is currently enrolled in any other investigational drug study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.To assess the efficacy of wound dressing applications (wound healing rate) in wound patients a)% of reduction in the wound size from the baseline till the end of Day 5 Timepoint: From Screening till the end of every visit From Screening till the end of study | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the safety of wound dressing applications 2. To assess the reduction in the wound pain (Pain Management)Timepoint: From the Screening till the end of every visit From the Screening till the end of the study | — |
Countries
India
Contacts
Public ContactMrs Nagalakshmi AnandaPadmanabhan
Srinivasam Cancer Care Hospital India
Outcome results
None listed